Rock Creek Group’s Thermo Fisher Scientific TMO Stock Holding History

Rock Creek Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-569	Closed	-$288K	–	167
2023 Q3	$288K	Sell	569 -92	-14%	-$49K	0.04%	73
2023 Q2	$345K	Sell	661 -59	-8%	-$31.8K	0.05%	74
2023 Q1	$415K	Buy	+720	New	+$406K	0.05%	71
2022 Q1	–	Sell	-526	Closed	-$351K	–	220
2021 Q4	$351K	Sell	526 -41	-7%	-$25.6K	0.05%	109
2021 Q3	$324K	Sell	567 -288	-34%	-$158K	0.05%	80
2021 Q2	$431K	Buy	855 +101	+13%	+$47.7K	0.06%	97
2021 Q1	$344K	Sell	754 -1,095	-59%	-$523K	0.06%	91
2020 Q4	$861K	Buy	1,849 +339	+22%	+$159K	0.35%	63
2020 Q3	$667K	Sell	1,510 -190	-11%	-$78.5K	0.34%	73
2020 Q2	$616K	Sell	1,700 -2,771	-62%	-$929K	0.33%	65
2020 Q1	$1.27M	Buy	4,471 +1,313	+42%	+$414K	0.7%	43
2019 Q4	$1.03M	Sell	3,158 -969	-23%	-$294K	0.41%	60
2019 Q3	$1.2M	Sell	4,127 -393	-9%	-$113K	0.57%	47
2019 Q2	$1.33M	Buy	4,520 +520	+13%	+$143K	0.61%	41
2019 Q1	$1.09M	Sell	4,000 -836	-17%	-$208K	0.49%	43
2018 Q4	$1.08M	Buy	+4,836	New	+$1.13M	0.47%	43

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Rock Creek Group's TMO Position: Q4 2023 in Review

Rock Creek Group sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 569 shares — an estimated $288K sold.

Rock Creek Group first reported a position in TMO in Q4 2018 and held it in 16 quarters. The position peaked at $1.33M in Q2 2019. 2,487 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

Rock Creek Group reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
Rock Creek Group sold 569 Thermo Fisher Scientific shares in Q4 2023, an estimated $288K.
Rock Creek Group first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 16 quarters.
Rock Creek Group's Thermo Fisher Scientific position peaked at $1.33M in Q2 2019.
2,487 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Rock Creek Group's 13F filing for Q4 2023, filed 13 Feb 2024.